Cargando…

Molecular assays for antimalarial drug resistance surveillance: A target product profile

Antimalarial drug resistance is a major constraint for malaria control and elimination efforts. Artemisinin-based combination therapy is now the mainstay for malaria treatment. However, delayed parasite clearance following treatment with artemisinin derivatives has now spread in the Greater Mekong S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nsanzabana, Christian, Ariey, Frederic, Beck, Hans-Peter, Ding, Xavier C., Kamau, Edwin, Krishna, Sanjeev, Legrand, Eric, Lucchi, Naomi, Miotto, Olivo, Nag, Sidsel, Noedl, Harald, Roper, Cally, Rosenthal, Philip J., Schallig, Henk D. F. H., Taylor, Steve M., Volkman, Sarah K., Gonzalez, Iveth J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147503/ https://www.ncbi.nlm.nih.gov/pubmed/30235327 http://dx.doi.org/10.1371/journal.pone.0204347

Ejemplares similares

Media, Health Workers, and Policy Makers' Relationship and Their Impact on Antimalarial Policy Adoption: A Population Genetics Perspective
por: Malisa, Allen, et al.
Publicado: (2011)

Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes
por: Gomes, Ana Rita, et al.
Publicado: (2017)

Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré
por: Bonnet, Maryline, et al.
Publicado: (2007)

World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria
por: Plowe, Christopher V, et al.
Publicado: (2007)

Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine–pyrimethamine in Tanzania
por: Kavishe, Reginald A., et al.
Publicado: (2016)

Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape
por: Nsanzabana, Christian, et al.
Publicado: (2018)

Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
por: Gomes, Ana Rita, et al.
Publicado: (2017)

Country-Wide Surveillance of Molecular Markers of Antimalarial Drug Resistance in Senegal by Use of Positive Malaria Rapid Diagnostic Tests
por: Ndiaye, Magatte, et al.
Publicado: (2017)

Repurposing Antimalarials to Tackle the COVID-19 Pandemic
por: Krishna, Sanjeev, et al.
Publicado: (2021)

Global survey of malaria rapid diagnostic test (RDT) sales, procurement and lot verification practices: assessing the use of the WHO–FIND Malaria RDT Evaluation Programme (2011–2014)
por: Incardona, Sandra, et al.
Publicado: (2017)

Surveillance of Travellers: An Additional Tool for Tracking Antimalarial Drug Resistance in Endemic Countries
por: Gharbi, Myriam, et al.
Publicado: (2013)

The Transit Phase of Migration: Circulation of Malaria and Its Multidrug-Resistant Forms in Africa
por: Lynch, Caroline, et al.
Publicado: (2011)

Drug resistance maps to guide intermittent preventive treatment of malaria in African infants
por: NAIDOO, INBARANI, et al.
Publicado: (2011)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
por: Plucinski, Mateusz, et al.
Publicado: (2022)

STARTER checklist for antimalarial therapeutic efficacy reporting
por: Plucinski, Mateusz M., et al.
Publicado: (2022)

Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane
por: Blank, Brian R., et al.
Publicado: (2017)

Coupling the Antimalarial Cell Penetrating Peptide TP10 to Classical Antimalarial Drugs Primaquine and Chloroquine Produces Strongly Hemolytic Conjugates
por: Aguiar, Luísa, et al.
Publicado: (2019)

Malaria genomics meets drug-resistance phenotyping in the field
por: Hunt, Paul, et al.
Publicado: (2009)

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa
por: Okell, Lucy C., et al.
Publicado: (2017)

Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)
por: Krishna, Sanjeev, et al.
Publicado: (2021)

Independent Origin of Plasmodium falciparum Antifolate Super-Resistance, Uganda, Tanzania, and Ethiopia
por: Alifrangis, Michael, et al.
Publicado: (2014)

Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
por: Nsanzabana, Christian
Publicado: (2019)

Strengthening Surveillance Systems for Malaria Elimination by Integrating Molecular and Genomic Data
por: Nsanzabana, Christian
Publicado: (2019)

Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa
por: Nsanzabana, Christian
Publicado: (2021)

Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
por: Ross, Leila S., et al.
Publicado: (2018)

An affordable antimalarial.
por: Tenenbaum, David J
Publicado: (2004)

Marine Antimalarials
por: Fattorusso, Ernesto, et al.
Publicado: (2009)

Synthetic Antimalarials
Publicado: (1955)

Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network
por: Cui, Liwang, et al.
Publicado: (2015)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial Use
por: Noranate, Nitchakarn, et al.
Publicado: (2007)

β-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: Synthesis and antimalarial evaluation
por: Nisha, et al.
Publicado: (2014)

Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies
por: Paton, Douglas G., et al.
Publicado: (2022)

A Genome Wide Association Study of Plasmodium falciparum Susceptibility to 22 Antimalarial Drugs in Kenya
por: Wendler, Jason P., et al.
Publicado: (2014)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
por: Okombo, John, et al.
Publicado: (2014)

Data on High Resolution Melting (HRM) and phylogenetic analysis of P. ovale wallikeri and P. ovale curtisi
por: Lamien-Meda, Aline, et al.
Publicado: (2019)

Comparison of intermittent screening (using ultra-sensitive malaria rapid diagnostic test) and treatment (using a newly registered antimalarial pyronaridine-artesunate—PYRAMAX®) to standard intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria in pregnant women living in endemic areas: ULTRAPYRAPREG
por: Maketa, Vivi, et al.
Publicado: (2022)

Antimalarial Work in Macedonia
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_6go0465dn6hk2o8t135eqedrji